Therapeutic Observation of Walking Qi Gong for Cancer


Shangdon Provincial TCM hospital, oncological division:

Since 1982, walking Qigong was adopted as the adjuvant cancer therapy. Of  the 1500 participants in 17 classes, 900 patients with mid- to later term cancer were studied. There were 684 male and 216 female, oldest 68 and youngest 16, averaging age 56; lung cancer 191, stomach cancer168, esophageal cancer 124, breast cancer 95, nasopharyngeal  cancer 69, lymphoma 54, colorectal cancer 49, liver cancer 45, thyroid cancer 8, osteo-sarcoma 4, and other types. All patients, except for 39 liver cancer cases,  were pathologi-cally and cytologically confirmed. Chemotherapy 598 and radiotherapy 302. Side-effects such as loss of appetite, general fatigue, weight loss, and insomnia occurred in 707 cases. 628 cases had white cell counts below 4000/mm3 and the rest were below 3000/mm3.

After 2 months of walking Qigong, Level One,  536 out of 707 cases experienced disappearance of above side-effects ( 75.8% effective). 418 cases out of 628 with white cell counts <4000/mm3  regained 1000-2000/mm3 ( 66% effective); 185 cases of 272 with white cells <3000/mm3 regained 1000-2000/mm3 ( 68% effective ) . The total rate effectiveness is 67%+. The hospital interpreted the results in favor of walking Qigong . The practice  is easy to learn and offers a means of self-treatment by conditioning the body, the mind, and the breathing. It conforms to the TCM principle of cultivating the ZhenQi and reveals satisfactory results in the combined cancer treatment.

Shangdon Hezhe Qigong Institute and Taishan Medical College joint study:

In September 1987, 71 patients participated in 22-day walking Qigong session for the joint study.  47 were cancer patients and 28 with other chronic diseases. The short-term results were summarized: 38 had increased energy, 28 higher appetite, 15 improved insomnia, 11 reduced pain, 3 decreased edema; hemorrhoids, influenza, and hypertension 1 each healed; fatigue, appetite loss, and insomnia 1 each persisted after the session.

Results from August 1992 follow-up yielded 23 response from 47 cancer patients. 6 died and 17 were in remission. The effective rate is 74% for the data collected.

Both short-term and 5-year followup pointed in favor of walking Qigong exercise.

Zibou Luzhong Hospital of Traditional Chinese Medicine:

Since 1991, 218 cancer cases underwent the trio treatment of Western, TCM, and walking Qigong. Of which 120 patients completed the study and were analysed below.

Male 84, female 36; oldest 81, youngest 17, average54. Cancer types 18, Clinical course from 38 days to 5 years.  41 cases had matastasis and 52 had surgical operation.

Group A used triple therapies. Group B used walking Qigong alone. Group C used regular treatment without walking qigong. The criteria included subjective appetite, energy, sleep, pain threshold; and objective findings from lab data and radiologic change. The effective rates for marked improvement were A35%>B12%>C3% and for subjective improvement  were A51%<B65%>C39%.

Walking Qigong can mobilize subjective consciousness and display the role of  will-power in strengthening immune functions and physical constitution; stabilizing biochemical index; reducing cancer symptoms and pain; and facilitating recovery.

Chemotherapy, radiotherapy, Chinese herbs, acupuncture, and Walking Qigong are all parts of a combination cancer treatment. Different cancer stages have major and adjuvant therapies. Careful plan and timely choice usually determine the course of events.

Excerpts translated by Oriental Healing of South Jersey from Goulin Walking Qigong PP309-395